Post-COVID-19 Afferent Baroreflex Failure

Hypertension. 2023 May;80(5):895-900. doi: 10.1161/HYPERTENSIONAHA.123.20316. Epub 2023 Feb 20.

Authors

Khaled Elkholey^{1

2}, Amr Wahba^{1

2}, Sachin Y Paranjape^{1

2}, Mohammad Saleem¹, Annet Kirabo, Karen M Joos³, André Diedrich^{1

2}, Cyndya A Shibao^{1

2}, Italo Biaggioni^{1

2}

Affiliations

¹ Divisions of Clinical Pharmacology, Department of Medicine (K.E., A.W., S.P., M.S., S.K., A.D., C.A.S., I.B.), Vanderbilt University Medical Center, Nashville, TN.
² Autonomic Dysfunction Center (K.E., A.W., S.Y.P., A.D., C.A.S., I.B.), Vanderbilt University Medical Center, Nashville, TN.
³ and Vanderbilt Eye Institute (K.M.J.), Vanderbilt University Medical Center, Nashville, TN.

No abstract available

Publication types

Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't

MeSH terms

Afferent Pathways
Baroreflex*
Blood Pressure
COVID-19*
Humans
Pressoreceptors
Sympathetic Nervous System